bullish

Miromatrix Medical: Bioengineering Human Organs. Next Big Medical Breakthrough?

289 Views08 Jul 2021 01:55
We believe that perfusion technology from Miromatrix differentiates from 3D bioprinting and genetically modified xenografts and has more advantages to develop high-quality bioengineered organs
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 26-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Rising
Andrei Zakharov
Covering IPOs, Healthcare and Technology Stocks
Information Technology & EnergyEquitiesEquity Capital MarketsThematic (Sector/Industry)
  • Miromatrix Medical: Bioengineering Human Organs. Next Big Medical Breakthrough?
    08 Jul 2021
x